BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

598 related articles for article (PubMed ID: 28911901)

  • 1. Structural Brain Abnormalities of Attention-Deficit/Hyperactivity Disorder With Oppositional Defiant Disorder.
    Noordermeer SDS; Luman M; Greven CU; Veroude K; Faraone SV; Hartman CA; Hoekstra PJ; Franke B; Buitelaar JK; Heslenfeld DJ; Oosterlaan J
    Biol Psychiatry; 2017 Nov; 82(9):642-650. PubMed ID: 28911901
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Altered brain morphology in boys with attention deficit hyperactivity disorder with and without comorbid conduct disorder/oppositional defiant disorder.
    Vetter NC; Backhausen LL; Buse J; Roessner V; Smolka MN
    Hum Brain Mapp; 2020 Mar; 41(4):973-983. PubMed ID: 31691449
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Neuroanatomical correlates of attention-deficit-hyperactivity disorder accounting for comorbid oppositional defiant disorder and conduct disorder.
    Sasayama D; Hayashida A; Yamasue H; Harada Y; Kaneko T; Kasai K; Washizuka S; Amano N
    Psychiatry Clin Neurosci; 2010 Aug; 64(4):394-402. PubMed ID: 20546170
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A Systematic Review and Meta-analysis of Neuroimaging in Oppositional Defiant Disorder (ODD) and Conduct Disorder (CD) Taking Attention-Deficit Hyperactivity Disorder (ADHD) Into Account.
    Noordermeer SD; Luman M; Oosterlaan J
    Neuropsychol Rev; 2016 Mar; 26(1):44-72. PubMed ID: 26846227
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The influence of comorbid oppositional defiant disorder on white matter microstructure in attention-deficit/hyperactivity disorder.
    van Ewijk H; Noordermeer SD; Heslenfeld DJ; Luman M; Hartman CA; Hoekstra PJ; Faraone SV; Franke B; Buitelaar JK; Oosterlaan J
    Eur Child Adolesc Psychiatry; 2016 Jul; 25(7):701-10. PubMed ID: 26507746
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cortical and Subcortical Gray Matter Volume in Youths With Conduct Problems: A Meta-analysis.
    Rogers JC; De Brito SA
    JAMA Psychiatry; 2016 Jan; 73(1):64-72. PubMed ID: 26650724
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The possible involvement of genetic variants of NET1 in the etiology of attention-deficit/hyperactivity disorder comorbid with oppositional defiant disorder.
    Liu L; Cheng J; Li H; Yang L; Qian Q; Wang Y
    J Child Psychol Psychiatry; 2015 Jan; 56(1):58-66. PubMed ID: 24942521
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Neurocognitive Deficits in Attention-Deficit/Hyperactivity Disorder With and Without Comorbid Oppositional Defiant Disorder.
    Noordermeer SDS; Luman M; Buitelaar JK; Hartman CA; Hoekstra PJ; Franke B; Faraone SV; Heslenfeld DJ; Oosterlaan J
    J Atten Disord; 2020 Jul; 24(9):1317-1329. PubMed ID: 26486602
    [No Abstract]   [Full Text] [Related]  

  • 9. Mapping brain structure in attention deficit-hyperactivity disorder: a voxel-based MRI study of regional grey and white matter volume.
    McAlonan GM; Cheung V; Cheung C; Chua SE; Murphy DG; Suckling J; Tai KS; Yip LK; Leung P; Ho TP
    Psychiatry Res; 2007 Feb; 154(2):171-80. PubMed ID: 17291727
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Does oppositional defiant disorder have temperament and psychopathological profiles independent of attention deficit/hyperactivity disorder?
    Kim HW; Cho SC; Kim BN; Kim JW; Shin MS; Yeo JY
    Compr Psychiatry; 2010; 51(4):412-8. PubMed ID: 20579516
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Health-related quality of life in children and adolescents who have a diagnosis of attention-deficit/hyperactivity disorder.
    Klassen AF; Miller A; Fine S
    Pediatrics; 2004 Nov; 114(5):e541-7. PubMed ID: 15520087
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Technetium 99m ethylcysteinate dimer single-photon emission computed tomography (SPECT) during intellectual stress test in children and adolescents with pure versus comorbid attention-deficit hyperactivity disorder (ADHD).
    Lorberboym M; Watemberg N; Nissenkorn A; Nir B; Lerman-Sagie T
    J Child Neurol; 2004 Feb; 19(2):91-6. PubMed ID: 15072100
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Developmentally stable whole-brain volume reductions and developmentally sensitive caudate and putamen volume alterations in those with attention-deficit/hyperactivity disorder and their unaffected siblings.
    Greven CU; Bralten J; Mennes M; O'Dwyer L; van Hulzen KJ; Rommelse N; Schweren LJ; Hoekstra PJ; Hartman CA; Heslenfeld D; Oosterlaan J; Faraone SV; Franke B; Zwiers MP; Arias-Vasquez A; Buitelaar JK
    JAMA Psychiatry; 2015 May; 72(5):490-9. PubMed ID: 25785435
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Neurocognitive function in attention-deficit-hyperactivity disorder with and without comorbid disruptive behaviour disorders.
    Barnett R; Maruff P; Vance A
    Aust N Z J Psychiatry; 2009 Aug; 43(8):722-30. PubMed ID: 19629793
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The long-term longitudinal course of oppositional defiant disorder and conduct disorder in ADHD boys: findings from a controlled 10-year prospective longitudinal follow-up study.
    Biederman J; Petty CR; Dolan C; Hughes S; Mick E; Monuteaux MC; Faraone SV
    Psychol Med; 2008 Jul; 38(7):1027-36. PubMed ID: 18205967
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hot and Cool Executive Functions in Children with Attention-Deficit/Hyperactivity Disorder and Comorbid Oppositional Defiant Disorder.
    Antonini TN; Becker SP; Tamm L; Epstein JN
    J Int Neuropsychol Soc; 2015 Sep; 21(8):584-95. PubMed ID: 26416095
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Atomoxetine versus placebo in children and adolescents with attention-deficit/hyperactivity disorder and comorbid oppositional defiant disorder: a double-blind, randomized, multicenter trial in Germany.
    Dittmann RW; Schacht A; Helsberg K; Schneider-Fresenius C; Lehmann M; Lehmkuhl G; Wehmeier PM
    J Child Adolesc Psychopharmacol; 2011 Apr; 21(2):97-110. PubMed ID: 21488751
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Association of ADHD and conduct disorder--brain electrical evidence for the existence of a distinct subtype.
    Banaschewski T; Brandeis D; Heinrich H; Albrecht B; Brunner E; Rothenberger A
    J Child Psychol Psychiatry; 2003 Mar; 44(3):356-76. PubMed ID: 12635966
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Executive functioning and emotion recognition in youth with oppositional defiant disorder and/or conduct disorder.
    Kleine Deters R; Naaijen J; Rosa M; Aggensteiner PM; Banaschewski T; Saam MC; Schulze UME; Sethi A; Craig MC; Sagar-Ouriaghli I; Santosh P; Castro-Fornieles J; Penzol MJ; Arango C; Werhahn JE; Brandeis D; Franke B; Glennon J; Buitelaar JK; Hoekstra PJ; Dietrich A
    World J Biol Psychiatry; 2020 Sep; 21(7):539-551. PubMed ID: 32212964
    [No Abstract]   [Full Text] [Related]  

  • 20. Characterization of cortical and subcortical abnormalities in drug-naive boys with attention-deficit/hyperactivity disorder.
    Lu L; Zhang L; Tang S; Bu X; Chen Y; Hu X; Hu X; Li H; Guo L; Sweeney JA; Gong Q; Huang X
    J Affect Disord; 2019 May; 250():397-403. PubMed ID: 30877863
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 30.